During the past decade, Osaka Medical Center and Research Institute for Maternal and Child Health conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 9 clinical trials were completed, i.e. on average, 56.3% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 6 clinical trials were completed. i.e. 85.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Osaka Medical Center and Research Institute for Maternal and Child Health" #1 sponsor was "Pfizer" with 10 trials, followed by "Ferring Pharmaceuticals" with 2 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored, "Japan Rhabdomyosarcoma Study Group" with 2 trials sponsored and "Shire" with 2 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Osaka Medical Center and Research Institute for Maternal and Child Health" #1 collaborator was "Japan Blood Products Organization" with 1 trials as a collaborator, "Maruishi Pharmaceutical" with 1 trials as a collaborator and "Takeda Development Center Americas, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Osaka Medical Center and Research Institute for Maternal and Child Health" are "Achondroplasia" (2 trials), "Cervical Ripening" (2 trials), "Nervous System Diseases" (2 trials), "Sarcoma" (2 trials) and "Apnea of Prematurity" (1 trials). Many other conditions were trialed in "Osaka Medical Center and Research Institute for Maternal and Child Health" in a lesser frequency.

Most popular intervention types in "Osaka Medical Center and Research Institute for Maternal and Child Health" are "Drug" (18 trials), "Biological" (4 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Dinoprostone" (2 trials), "Placebo" (2 trials), "SHP615" (2 trials), "cyclophosphamide" (2 trials) and "dactinomycin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Osaka Medical Center and Research Institute for Maternal and Child Health" are 18 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Osaka Medical Center and Research Institute for Maternal and Child Health". undefined are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Osaka Medical Center and Research Institute for Maternal and Child Health, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Osaka Medical Center and Research Institute for Maternal and Child Health, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".